Back to calendar
Kalaris Therapeutics, Inc. (KLRS) Earnings
KLRS reports earnings on Wednesday, November 18, 2026
earnings report
November 18, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.52
Actual EPS: $-0.48
EPS surprise: 3.03%
Company overview
Market Cap$44.1M
PriceUSD 2.02
EPS (TTM)-2.01
52-week high11.88
52-week low1.78
SectorHealth Technology
IndustryBiotechnology
Employees20